AGE MANAGEMENT THERAPEUTICS Trademark

Trademark Overview


On Thursday, June 12, 2003, a trademark application was filed for AGE MANAGEMENT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AGE MANAGEMENT THERAPEUTICS trademark a serial number of 78261650. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 24, 2015. This trademark is owned by UNIFUND CORPORATION LIMITED. The AGE MANAGEMENT THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations, sold only by prescription, in the form of powders used as a neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer for the elimination of anxiety and hyperactivity, mitigation of panic symptomology, reduction of fatigue, improvement of self-confidence and self-esteem, elimination of the need for anti-depressants, cognitive enhancement, improvement of aerobic endurance and performance and weight-training capacity, improvement of blood circulation, reduction of blood pressure and hypertension, improvement of sexual performance and libido, reduction of hormonal imbalance in menopausal and post-menopausal women, improvement of visual and auditory acuity, improvement of physical agility and muscle flexibility, improvement of social interaction skills, promotion of relaxation response and mitigation of chronic sleep pattern disorders such as insomnia and other chronic sleep disorders, reduction of arthritic pain and swelling, e...

General Information


Serial Number78261650
Word MarkAGE MANAGEMENT THERAPEUTICS
Filing DateThursday, June 12, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 24, 2015
Registration Number2888015
Registration DateTuesday, September 21, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicinal preparations, sold only by prescription, in the form of powders used as a neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer for the elimination of anxiety and hyperactivity, mitigation of panic symptomology, reduction of fatigue, improvement of self-confidence and self-esteem, elimination of the need for anti-depressants, cognitive enhancement, improvement of aerobic endurance and performance and weight-training capacity, improvement of blood circulation, reduction of blood pressure and hypertension, improvement of sexual performance and libido, reduction of hormonal imbalance in menopausal and post-menopausal women, improvement of visual and auditory acuity, improvement of physical agility and muscle flexibility, improvement of social interaction skills, promotion of relaxation response and mitigation of chronic sleep pattern disorders such as insomnia and other chronic sleep disorders, reduction of arthritic pain and swelling, enhancement of immune system functioning, improvement of the metabolism, relief from constipation, improvement of skin tone, mitigation of "jet lag," and reduction in caffeine dependence; and the treatment of a broad spectrum of conditions and pathologies, namely, age-related and neuro-degenerative conditions and pathologies, nerve diseases, general anxiety disorder, depression, neurosis, neurasthenia, obsessive-compulsive disorder, chronic sleep disorder, chronic fatigue syndrome, digestive diseases, chronic constipation, hypertension, osteoarthritis pain and swelling, and human sexual desire disorder

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 24, 2015
Primary Code005
First Use Anywhere DateSunday, April 7, 2002
First Use In Commerce DateWednesday, April 10, 2002

Trademark Owner History


Party NameUNIFUND CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBEVERLY HILLS, CA 90210

Party NameUNIFUND CORPORATION LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLONDON E1 6EU
GB

Party NameUNIFUND CORPORATION LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLONDON E1 6EU
GB

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressLos Angeles, CA 90046

Trademark Events


Event DateEvent Description
Friday, April 24, 2015CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tuesday, March 8, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 8, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 10, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, March 10, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 3, 2010TEAS SECTION 8 RECEIVED
Wednesday, March 3, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 21, 2006REVIEW OF CORRESPONDENCE COMPLETE
Friday, July 22, 2005PAPER RECEIVED
Monday, November 22, 2004SEC 7 REQUEST FILED
Monday, November 22, 2004PAPER RECEIVED
Tuesday, September 21, 2004REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, July 14, 2004APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, July 14, 2004EXAMINERS AMENDMENT E-MAILED
Tuesday, June 29, 2004PAPER RECEIVED
Tuesday, June 8, 2004AMENDMENT FROM APPLICANT ENTERED
Tuesday, June 8, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 8, 2004PAPER RECEIVED
Thursday, April 22, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 18, 2003NON-FINAL ACTION E-MAILED
Tuesday, December 16, 2003ASSIGNED TO EXAMINER